28. Logan RFA. Problems and pitfalls in epidemiological studies of coeliac disease. In: Auricchio S, Visakorpi JK, eds. Common Food Intolerances 1. Epidemiology of Coeliac Disease (Dynamic Nutrition Research)(Pt 1). Basel, Switzerland: Karger; 1992:14-22.
29. Marsh MN. Gluten, major histocompatibility complex, and the small intestine: a molecular and immunobiologic approach to the spectrum of gluten sensitivity (‘celiac sprue’). Gastroenterology. 1992;102(1):330-354.
30. Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol. 1999;11(10):1185-1194.
31. Corazza GR, Villanaci V. Coeliac disease.
J Clin Pathol. 2005;58(6):573-574.
32. Hadithi M, von Blomberg BM, Crusius JB, et al. Accuracy of serologic tests and HLA-DQ typing for diagnosing celiac disease. Ann Intern Med. 2007;147(5):294-302.
33. Lerner A. New therapeutic strategies for celiac disease. Autoimmun Rev. 2010;9(3):144-147.
34. Catassi C, Fasano A. Celiac disease diagnosis: simple rules are better than complicated algorithms. Am J Med. 2010;123(8):691-693.
35. Rubio-Tapia A, Kyle RA, Kaplan EL, et al. Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology. 2009; 137(1):88–93.
36. Harewood GC, Holub JL, Lieberman DA. Variation in small bowel biopsy performance among diverse endoscopy settings: results from a national endoscopic database. Am J Gastroenterol. 2004;99(9):1790-1794.
37. Brar P, Lee S, Lewis S, et al. Budesonide in the treatment of refractory celiac disease. Am J Gastroenterol. 2007;102(10):2265-2269.
38. Al-Toma A, Verbeek WHM, Hadithi M, et al. Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience. Gut. 2007;56(10):1373-1378.
39. Kaukinen K, Mäki M, Partanen J, et al. Celiac disease without villous atrophy: revision of criteria called for. Dig Dis Sci. 2001;46(4):879-887.
40. Mohamed BM, Feighery C, Coates C, et al. The absence of a mucosal lesion on standard histological examination does not exclude diagnosis of celiac disease. Dig Dis Sci. 2008; 53(1):52-61.
41. Fasano A, Catassi C. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology. 2001; 120(3):636-651.
42. US Food and Drug Administration. Topic-specific labeling information (2010). www.fda.gov/Food/LabelingNutrition/FoodLabeling GuidanceRegulatoryInformation/Topic-Specific LabelingInformation/default.htm. Accessed March 28, 2011.
43. Lindfors K, Blomqvist T, Juuti-Uusitalo K, et al. Live probiotic Bifidobacterium lactis bacteria inhibit the toxic effects induced by wheat gliadin in epithelial cell culture. Clin Exp Immunol. 2008;152(3):552-558.
44. Cellier C, Delabesse E, Helmer C, et al; French Coeliac Disease Study Group. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. Lancet. 2000;356(9225): 203-208.
45. United European Gastroenterology. When is a coeliac a coeliac? Report of a working group of the United European Gastroenterology Week in Amsterdam, 2001. Eur J Gastroenterol Hepatol. 2001;13(9):1123-1128.
46. Malamut G, Afchain P, Verkarre V, et al. Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II. Gastroenterology. 2009;136(1):81-90.
47. Al-Toma A, Goerres MS, Meijer JW, et al. Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma. Clin Gastroenterol Hepatol. 2006;4(3): 315-319.
48. Mauriño E, Niveloni S, Cherñavsky A, et al. Azathioprine in refractory sprue: results from a prospective, open-label study. Am J Gastroenterol. 2002;97(10):2595–2602.
49. Tack GJ, Verbeek WHM, Al-Toma A, et al. Evaluation of cladribine treatment in refractory celiac disease type II. World J Gastroenterol. 2011;17(4):506–513.
50. Akobeng AK, Ramanan AV, Buchan I, Heller RF. Effect of breast feeding on risk of coeliac disease: a systematic review and meta-analysis of observational studies. Arch Dis Child. 2006; 91(1):39-43.
51. Rashid M, Butzner JD, Warren R, et al. Home blood testing for celiac disease: recommendations for management. Can Fam Physician. 2009;55(2):151-153.
52. Hershcovici T, Leshno M, Goldin E, et al. Cost effectiveness of mass screening for coeliac disease is determined by time-delay to diagnosis and quality of life on a gluten-free diet. Aliment Pharmacol Ther. 2010;31(8):901-910.